A few years ago, David Price, head of Vertex Pharmaceuticals’ Oxford research site was diagnosed with a brain tumour and was admitted to a Boston hospital for surgery and treatment. The experience reaffirmed his unshakable faith in the power of medical research. Today, David and his team work on early research dedicated to cracking the biology and pouring on the chemistry in their multiple research programs, with the ambition to potentially transform the lives of people living with serious diseases and conditions.
In a compelling podcast from New Scientist CoLab, David shares his remarkable story and provides a rare look inside one of the world’s most innovative biopharmaceutical companies. |
